PTPN22 and neoplasm: These findings show that T cells lacking PTPN22 initially undergo greater expansion in response to tumor antigens, however, when tumors are not cleared and thus antigen persists, Ptpn22KO cells that are chronically exposed to antigen in vivo fail to sustain proliferation and/or die more rapidly.